HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 194 filers reported holding HAEMONETICS CORP in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $5,922,000 | +6.8% | 169,300 | -1.6% | 2.28% | +3.0% |
| Q4 2015 | $5,545,000 | -13.4% | 172,000 | -13.2% | 2.22% | -0.7% |
| Q3 2015 | $6,404,000 | -22.8% | 198,150 | -1.2% | 2.23% | -12.9% |
| Q2 2015 | $8,299,000 | -53.5% | 200,650 | -49.5% | 2.56% | +5.0% |
| Q1 2015 | $17,862,000 | +16.5% | 397,650 | -2.9% | 2.44% | +19.5% |
| Q4 2014 | $15,329,000 | +4.9% | 409,650 | -2.1% | 2.04% | -1.2% |
| Q3 2014 | $14,616,000 | -4.3% | 418,550 | -3.3% | 2.07% | +8.7% |
| Q2 2014 | $15,278,000 | +6.2% | 433,050 | -1.9% | 1.90% | +6.6% |
| Q1 2014 | $14,380,000 | -24.6% | 441,250 | -2.5% | 1.78% | -23.9% |
| Q4 2013 | $19,060,000 | -13.0% | 452,400 | -17.6% | 2.34% | +4.1% |
| Q3 2013 | $21,902,000 | -5.3% | 549,200 | -1.8% | 2.25% | -12.2% |
| Q2 2013 | $23,127,000 | – | 559,300 | – | 2.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |